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Phospholipase A2 activity was shown indirectly in T-lymphocytes from rat thyrnus and a permanent T-cell 
line by the liberation of arachidonic acid from phospholipids. In addition, phospholipase A2 activity was 
measured directly with two different substrates, phosphatidylcholine and labelled E. cofi. 
Phospholipase A* 
I. INTRODUCTIGN 
In cellular membranes the composition of 
phospholipids is in a dynamic equilibrium. Long- 
chain fatty acyl moieties of membrane 
phospholipids are rapidly turned over by a 
metabolic pathway first described by Lands and 
Merkl [I]. In this pathway a fatty acid is cleaved 
from the glycerol backbone to generate 
lysophospholipids, which are then reacylated by 
the enzyme lysophosphatide acyltransferase. Due 
to the properties of the lysophosphatide 
acyltransferase polyenoic fatty acids can be in- 
troduced into phospholipids 121. In addition, 
deacylation-reacylation reactions can alter the 
composition of phospholipids. The first step in this 
cycle, the cleavage of the fatty acyl moiety, is 
thought to be brought about by the activity of a 
phospholipase AZ, an enzyme that has been shown 
to be active in many different cell types [3]. T- 
lymphocytes rapidly incorporate exogenous long- 
chain fatty acids, including polyunsaturated ones, 
indicating that the deacylation-reacylation cycle is 
operative [4J. Accordingly, lysophosphatide 
acyltransferase has been shown to be present in 
lymphocytes f5J. Up to now, however, attempts to 
show phospholipase AZ failed [6f, although a 
release of fatty acids could be observed, when 
prelabelled intact cells were investigated [7,8]. 
T-lymphocyte 
These results were explained by another 
mechanism of fatty acid exchange, a CoA- 
mediated transfer of fatty acids catalyzed by the 
back reaction of the lysophosphatide acyltrans- 
ferase [6,7]. Free fatty acids could then be 
generated by hydrolysis of the intermediate fatty 
acyl-CoA derivative. In a recent paper, Etienne 
and Polonovski [9] could directly demonstrate 
phospholipase A2 activity in lymphocytes from 
human and rat peripheral blood. Their prepara- 
tions, however, contain mononuclear phagocytes, 
which contain considerable phospholipase activity. 
Therefore, we investigated whether phospholipase 
AZ activity could also be demonstrated in pure T- 
lymphocytes. 
2. EXPERIMENTAL 
2.1. cells 
T-lymphocytes from the thymus of Lewis rats 
were prepared as described (lo]. Pure T- 
lymphocytes were obtained from the permanent in- 
terleukin 2-dependent T-cell line G2 from BH rats 
(kindly provided by Dr K. Wonigeit, Hannover), 
Thymocytes from rats or G2 cells were in- 
cubated in Hepes-buffered RPM1 1640 (Seromed), 
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celI density 5 x 107 cells/ml, with f nmof/107 cells 
arachidonic acid (Nu Chek Prep) and an ap- 
propriate amount of radioactive arachidonic acid 
(0.05 ,&X/assay, Amersham). After 1 h the cells 
were washed with medium containing 0.5% bovine 
serum albumin (BSA, essentially fatty acid-free, 
Sigma) to remove remaining free fatty acid. The 
cells were then resuspended at the same density and 
further incubated with or without an excess of 
oleic acid (35 nmol~107 cells) in medium contain- 
ing 0.5% BSA. The incubation was terminated by 
the addition of methanol and subsequent lipid ex- 
traction as in fl I]_ Lipids were separated by thin- 
layer chromatography. The amount of radioactivi- 
ty in the individual lipids was determined by liquid 
scintillation counting. 
2.3. Preparation of cell homogenates 
The ceils were resuspended in phosphate- 
buffered saline (PBS) and frozen. Subsequently 
they were homogenized by brief sonication (10 s, 
50 W). Protein was determined by the method of 
Bradford fl2]. 
Phospholipase AZ was measured using two dif- 
ferent assay systems. (i) Mixed lipid vesicles were 
prepared according to [ 131: 0.5 pmol 1 -palmitoyI- 
2oleoylphosphatidylcholine (Sigma), 0.14 pmol 
oleic acid (Sigma), 0.14 pmol l-palmitoyl-sn- 
glycerophosphatidylcholine and an appropriate 
amount of (14C) l-palmitoyl-2-oleoyl-]l-‘*C]phos- 
phatidyIchoIine (about 20000 cpm, NEN) were 
dried under nitrogen, resuspended in 500~1 bi- 
distilled water and sonicated for I h in a sonicating 
bath (50 W, fXF+C). The vesicles used as substrate 
could be kept at room temperature for several 
days. 150-200 Fg cefl protein were incubated with 
SO f%l substrate (final concentration of 
phosphatidylcholine: 25 nmol/ml) in a total 
volume of 500~1 buffer (25 mM Tris-HCl, pH 8, 
0.5 mM CaC12) for 3-5 h. The reaction was ter- 
minated by the addition of methanol and sub- 
sequent lipid extraction [I 1) and separation of the 
liberated free fatty acid from unreacted substrate 
by thin-layer chromatography. (ii) E. coil (JM 103) 
were grown in Mueller Hinton broth (Mast Diag- 
nostica) and Iabelled with g3H]oleic acid in the 
logarithmic phase of growth, The celts were 
autoclaved for 30 min and subsequently washed 
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several times with 0.2 M Tris-HCI, pH 8, with I% 
BSA to remove free oleic acid. The amount of E. 
cofi used in the assay was determined by 
the amount of radioactivity needed (about 
50000 cpm). The corresponding amount of 
phospholipid was determined after extraction and 
quantitative phosphorus determination [l l] to be 
about 15 nmol/ml in the assay. This quantity, 
however, could not be used for the exact deter- 
mination of ~hosphoIipase activity as the Iabei was 
not distributed evenly among the different 
phosphoIip~d species, but acyfated predomin~tly 
to position 2 of phosphat~dyIethanolam~ne (f14] 
and nnpublished~. Therefore, activity was ex- 
pressed as percent cleavage corrected to controls, 
i.e. incubations without homogenates. (For de- 
tailed assay conditions see section 3.) The reaction 
was terminated by the addition of 500 ~1 of 10 mM 
EDTA and 1% BSA to trap the liberated fatty acid 
1151. After centrifugation in an Eppendorf cen- 
trifuge aliquots of the supernatant were counted to 
determine the percentage of liberated fatty acid. 
3. RESULTS 
3.1. Release af ara~hidonic acid 
We could show earlier 141 that T-lymphocytes 
from mice, prelabelled with arachidonic acid, 
released arachidonic acid into an incubation 
medium supplemented with defatted albumin. 
However, the source of the liberated arachidonic 
acid could not be determined definitely, as 
radioactivity was lost from phospholipids as we11 
as from triacylglycerois. In rat thymocytes the 
triacylglycerol pool was only m~g~na~ly affected. 
As can be seen from fig-la the increase of 
arachidonic acid in the medium corresponded to a 
decrease of Iabel in the cellular phospholipid pool. 
Addition of exogenous oleic acid further increased 
the amount of liberated fatty acid: 8.8 f 3.3% 
arachidonic acid released compared to 5.7 rfc 0.9% 
in control cells after 120 min (n = 3 independent 
experiments). These results were most easily inter- 
preted as an enhanced turnover of the deacylation- 
reacylation cycle. To exclude the possibility, 
though unlikely, that the effects observed were due 
to a smafl contamination of macrophages, the ex- 
periments were repeated with the rat cell line G2. 
In these pure T-cells fatty acids were also released. 
As can be seen from fig.lb, there was also some 
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Fig. 1. Liberation of arachidonic acid from prelabelled 
T-lymphocytes. Thymocytes from rats (a} or G2 T-ceIIs 
(b) were prelabelied with f’4C]arachidonic acid. After 
washing they were further incubated in the presence 
(open symbols) or absence (closed symbols) of 
exogenous oleic acid. Data shown are from typical 
experiments with duplicate incubations; differences were 
less than the symbols. 
release of fatty acids from the triacylglycerol pool, 
phospholipids, however, were the main source of 
arachidonic acid. 
3.2. Characterization ofphospholipase At activity 
in T-lymphocytes 
Most of the measurements were performed with 
Iabelled E. coli as substrate. Phospholipid vesicles 
were used to prove the specific cleavage of a fatty 
acid from position 2 of a defined phosphatidyl- 
choline. Pbospholipase At activity was linear over 
several hours, the specific activity being 0.8 f 
0.1 nmol oleic acid/mg protein per h (two indepen- 
dent preparations with multiple determinations). 
The enzyme showed some similarities to the one 
described in the lymphocyte preparation from 
peripheral blood [9]: the pH optimum was at pH 
7.5 (fig.2); the enzymatic activity was suppressed 
at Ca*+ concentrations higher than 5 mM and by 
detergents uch as Triton X-100, cholate and deox- 
ycholate. There was a marked increase in en- 
zymatic activity when Hepes was used as buffer 
compared to Tris-HCl with the same molar&y and 
pH. Addition of SDS to the cells prior to cell 
01 
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Fig.2. pH dependence of phosphohpase A2 activity. 
Phospholip~e As activity was determined with labelled 
E. cob as substrate. Assay conditions: 1 mM CaClz, 
50 mM Hepes, 0.1 mglml protein, 60 min, 37°C. Data 
are means of two preparations of thymocytes (e) and 
G2 T-cells (A). 
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disr~pti~n by sonication did rml incrttase th  
phospho~jp~e A2 activity as describe for bhod 
jymph~cytes- 
Similsxr char2cterjs~ics were found for the 
~~~~~b~~~pase A2 ctivity of the C2 ISnc. As an ex- 
ample the pH dependence is shown Sxz fig.3. 
4, DISCUSSION 
Using similar methods, we could not detect 
respective activities in other species, i,e, calf and 
mouse, Tn homogenates prepared from mouse 
thymus (DBAL!), calf thymus and an interIeukin 
2~d~p~~de~~ mouse T-cell helper clone no 
~hos~bolip~e activity was det~~t~~~e at nentrd 
pH under varying assay ~o~d~t~o~s (ionic strength, 
Ca’” ~o~~~ntrat~on~ addition of SDS>, fn eff 
tb~mo~~es we eoufd detect ~~~~~~~~~~a~~ activity 
only at an acid pH. Sever& reasons may account 
for these differences among pre~ar~t~~~s from dif- 
ferent species. (i) Optimal assay conditions vary 
widely for different phospholEp@%s, especially 
with regard to detergent requiremeurts, Eukaryotic 
phaspholipases are often membrane bound and 
thus embedded in a lipid surro~l~din~ that ensures 
easy substrate access. In vitro, neither the enzyme 
xxx the substrate is wa~er-so~u~~~ and, if no activi- 
ty is ~~t~eta~~e~ this may just be ar problem of ac- 
~~ss~~~~~t~. A~~ss~b~~~iy of the ~~~~~ soti@ be &I- 
ptoveci by SDS at few ~o~~~~r2~i~~~ in the case of 
p~~i~~~~~~ blood lymphocytes 191, but WBS without 
effect in our system. (ii) End~ge~~~s ~bib~tors f 
phospboXipase activity were recently described. 
Balleu and Cheung [ 161 demonstrzlted that un- 
saturated fatty acids were potent inhibitors of 
human platelet phospholipase AZ. Hydrox- 
y~~c~~~~ntanoie acid, an ar%c~i~o~i~ acid 
derjv~tive~ co&d be shrtwn to i~~~~~t phos- 
~~~jip~s~ AZactivity when added ~~o~en~~s~y ff7f 
and rn~~ht be an endogenous ~~~~b~tor as we%. 
These or other not yet detected inhibitors might be 
&so active En ~yrn~ho~~es. 
tands, wara, and 1werk1, f. ff9633) 5, 53i0i. 
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